Department of Hematology-Oncology, National University Cancer Institute, Singapore, National University Health System, 1E Kent Ridge Road, Singapore 119228, Singapore.
Cells. 2020 Mar 3;9(3):601. doi: 10.3390/cells9030601.
Multiple myeloma is a complex disease and immune dysfunction has been known to play an important role in the disease pathogenesis, progression, and drug resistance. Recent efforts in drug development have been focused on immunotherapies to modify the MM disease process. Here, we summarize the emerging immunotherapies in the MM treatment landscape.
多发性骨髓瘤是一种复杂的疾病，免疫功能障碍已被证实在疾病发病机制、进展和耐药性中发挥重要作用。最近药物研发的重点是免疫疗法，以改变 MM 的疾病进程。在这里，我们总结了多发性骨髓瘤治疗领域新兴的免疫疗法。
